Intravenous fibrinolytic therapy for acute stroke in Shanxi: a questionnaire survey
10.3969/j.issn.1002-0152.2015.12.004
- VernacularTitle:山西省神经内科医师脑梗死静脉溶栓问卷调查分析
- Author:
Liansheng MA
;
Wei ZHANG
;
Xiaoyuan NIU
;
Yalan FANG
- Publication Type:Journal Article
- Keywords:
Cerebral infarction;
Intravenous fibrinolysis;
Questionnaire
- From:
Chinese Journal of Nervous and Mental Diseases
2015;41(12):720-723
- CountryChina
- Language:Chinese
-
Abstract:
Objetive To investigate physicians'knowledge regarding intravenous fibrinolytic therapy for acute ischemic stroke and whether their hospitals could meet the requirements for the therapy. Methods Questionnaires were mailed to 500 physicians from 153 hospitals in Shanxi including 112 secondary and 41 tertiary hospitals. 370 physicians returned valid questionnaires. Results One hundred thirty-four hospitals (87.6%) could provide 24-hour computed to?mography service, including 95 (84.8%) secondary hospitals and 39 (95.1%) tertiary hospitals. Alteplase stock was avail?able in 59 hospitals (38.6%), containing 25 (22.3%) secondary and 34 (82.9%) tertiary hospitals. Accuracy rates of 13 questions regarding intravenous fibrinolytic therapy for acute ischemic stroke ranged from 30.8% to 82.9%. Accuracy rates of 6 questions were lower than 50.0%. Conclusions The present study has revealed that physicians in this study have poor knowledge regarding the therapy. The situation can not meet the demand of healthcare, which partially ac?counts for the low rate in fibrinolytic therapy in Shanxi. Relevant training and suitable assessment should be carried out compulsively to ensure that physicians grasp necessary knowledge and skills.
